US 11261237
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection
granted A61KA61K38/00A61K47/54
Quick answer
US patent 11261237 (Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
- Grant date
- Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K38/00, A61K47/54, A61K47/542, A61K47/55